StockData
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd (RDY) stock

RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.79+0.09 (+0.61%)

Close on Nov 17, 2026Market cap $12.34BP/E 27.1Yield 0.57%

Dr Reddys Laboratories price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Dr Reddys Laboratories's price to sales ratio was 3.5× on Nov 11, 2026, against 3.2× a year earlier. Over the last 5 years it ranged from 2.8× to 4.3×, with a median of 3.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.5×+0.2
2025Dec 31, 20253.2×−0.8
2024Dec 31, 20244.0×+0.1
2023Dec 29, 20233.9×+0.6
2022Dec 30, 20223.3×−0.9
2021Dec 31, 20214.3×−0.7
2020Dec 31, 20204.9×+1.8
2019Dec 31, 20193.1×+0.1
2018Dec 31, 20183.1×+0.2
2017Dec 29, 20172.9×−0.5
2016Dec 30, 20163.4×–

More Dr Reddys Laboratories figures

See a number that looks wrong?